Global Immunotherapy Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Immunotherapy will have significant change from previous year. According to our (LP Information) latest study, the global Immunotherapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Immunotherapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Immunotherapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Immunotherapy market, reaching US$ million by the year 2028. As for the Europe Immunotherapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Immunotherapy players cover Abbvie, Amgen, Inc., Biogen, and Bristol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunotherapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Immunotherapy will have significant change from previous year. According to our (LP Information) latest study, the global Immunotherapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Immunotherapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Immunotherapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Immunotherapy market, reaching US$ million by the year 2028. As for the Europe Immunotherapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Immunotherapy players cover Abbvie, Amgen, Inc., Biogen, and Bristol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunotherapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Monoclonal Antibodies
- Therapeutic Vaccines
- Checkpoint Inhibitors
- Non-Specific Immunotherapy
- Oncology
- Inflammation
- Central Nervous System
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbvie
- Amgen, Inc.
- Biogen
- Bristol-Myers Squibb
- Celgene
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunotherapy Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Immunotherapy by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Immunotherapy by Country/Region, 2017, 2022 & 2028
2.2 Immunotherapy Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Therapeutic Vaccines
2.2.3 Checkpoint Inhibitors
2.2.4 Non-Specific Immunotherapy
2.3 Immunotherapy Sales by Type
2.3.1 Global Immunotherapy Sales Market Share by Type (2017-2022)
2.3.2 Global Immunotherapy Revenue and Market Share by Type (2017-2022)
2.3.3 Global Immunotherapy Sale Price by Type (2017-2022)
2.4 Immunotherapy Segment by Application
2.4.1 Oncology
2.4.2 Inflammation
2.4.3 Central Nervous System
2.4.4 Others
2.5 Immunotherapy Sales by Application
2.5.1 Global Immunotherapy Sale Market Share by Application (2017-2022)
2.5.2 Global Immunotherapy Revenue and Market Share by Application (2017-2022)
2.5.3 Global Immunotherapy Sale Price by Application (2017-2022)
3 GLOBAL IMMUNOTHERAPY BY COMPANY
3.1 Global Immunotherapy Breakdown Data by Company
3.1.1 Global Immunotherapy Annual Sales by Company (2020-2022)
3.1.2 Global Immunotherapy Sales Market Share by Company (2020-2022)
3.2 Global Immunotherapy Annual Revenue by Company (2020-2022)
3.2.1 Global Immunotherapy Revenue by Company (2020-2022)
3.2.2 Global Immunotherapy Revenue Market Share by Company (2020-2022)
3.3 Global Immunotherapy Sale Price by Company
3.4 Key Manufacturers Immunotherapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immunotherapy Product Location Distribution
3.4.2 Players Immunotherapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMMUNOTHERAPY BY GEOGRAPHIC REGION
4.1 World Historic Immunotherapy Market Size by Geographic Region (2017-2022)
4.1.1 Global Immunotherapy Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Immunotherapy Annual Revenue by Geographic Region
4.2 World Historic Immunotherapy Market Size by Country/Region (2017-2022)
4.2.1 Global Immunotherapy Annual Sales by Country/Region (2017-2022)
4.2.2 Global Immunotherapy Annual Revenue by Country/Region
4.3 Americas Immunotherapy Sales Growth
4.4 APAC Immunotherapy Sales Growth
4.5 Europe Immunotherapy Sales Growth
4.6 Middle East & Africa Immunotherapy Sales Growth
5 AMERICAS
5.1 Americas Immunotherapy Sales by Country
5.1.1 Americas Immunotherapy Sales by Country (2017-2022)
5.1.2 Americas Immunotherapy Revenue by Country (2017-2022)
5.2 Americas Immunotherapy Sales by Type
5.3 Americas Immunotherapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunotherapy Sales by Region
6.1.1 APAC Immunotherapy Sales by Region (2017-2022)
6.1.2 APAC Immunotherapy Revenue by Region (2017-2022)
6.2 APAC Immunotherapy Sales by Type
6.3 APAC Immunotherapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immunotherapy by Country
7.1.1 Europe Immunotherapy Sales by Country (2017-2022)
7.1.2 Europe Immunotherapy Revenue by Country (2017-2022)
7.2 Europe Immunotherapy Sales by Type
7.3 Europe Immunotherapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunotherapy by Country
8.1.1 Middle East & Africa Immunotherapy Sales by Country (2017-2022)
8.1.2 Middle East & Africa Immunotherapy Revenue by Country (2017-2022)
8.2 Middle East & Africa Immunotherapy Sales by Type
8.3 Middle East & Africa Immunotherapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immunotherapy
10.3 Manufacturing Process Analysis of Immunotherapy
10.4 Industry Chain Structure of Immunotherapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immunotherapy Distributors
11.3 Immunotherapy Customer
12 WORLD FORECAST REVIEW FOR IMMUNOTHERAPY BY GEOGRAPHIC REGION
12.1 Global Immunotherapy Market Size Forecast by Region
12.1.1 Global Immunotherapy Forecast by Region (2023-2028)
12.1.2 Global Immunotherapy Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immunotherapy Forecast by Type
12.7 Global Immunotherapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbvie
13.1.1 Abbvie Company Information
13.1.2 Abbvie Immunotherapy Product Offered
13.1.3 Abbvie Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbvie Main Business Overview
13.1.5 Abbvie Latest Developments
13.2 Amgen, Inc.
13.2.1 Amgen, Inc. Company Information
13.2.2 Amgen, Inc. Immunotherapy Product Offered
13.2.3 Amgen, Inc. Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Amgen, Inc. Main Business Overview
13.2.5 Amgen, Inc. Latest Developments
13.3 Biogen
13.3.1 Biogen Company Information
13.3.2 Biogen Immunotherapy Product Offered
13.3.3 Biogen Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biogen Main Business Overview
13.3.5 Biogen Latest Developments
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Information
13.4.2 Bristol-Myers Squibb Immunotherapy Product Offered
13.4.3 Bristol-Myers Squibb Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bristol-Myers Squibb Main Business Overview
13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Celgene
13.5.1 Celgene Company Information
13.5.2 Celgene Immunotherapy Product Offered
13.5.3 Celgene Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Celgene Main Business Overview
13.5.5 Celgene Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Immunotherapy Product Offered
13.6.3 Johnson & Johnson Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Immunotherapy Product Offered
13.7.3 Merck Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Immunotherapy Product Offered
13.8.3 Novartis Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer Immunotherapy Product Offered
13.9.3 Pfizer Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 Roche
13.10.1 Roche Company Information
13.10.2 Roche Immunotherapy Product Offered
13.10.3 Roche Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Roche Main Business Overview
13.10.5 Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunotherapy Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Immunotherapy by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Immunotherapy by Country/Region, 2017, 2022 & 2028
2.2 Immunotherapy Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Therapeutic Vaccines
2.2.3 Checkpoint Inhibitors
2.2.4 Non-Specific Immunotherapy
2.3 Immunotherapy Sales by Type
2.3.1 Global Immunotherapy Sales Market Share by Type (2017-2022)
2.3.2 Global Immunotherapy Revenue and Market Share by Type (2017-2022)
2.3.3 Global Immunotherapy Sale Price by Type (2017-2022)
2.4 Immunotherapy Segment by Application
2.4.1 Oncology
2.4.2 Inflammation
2.4.3 Central Nervous System
2.4.4 Others
2.5 Immunotherapy Sales by Application
2.5.1 Global Immunotherapy Sale Market Share by Application (2017-2022)
2.5.2 Global Immunotherapy Revenue and Market Share by Application (2017-2022)
2.5.3 Global Immunotherapy Sale Price by Application (2017-2022)
3 GLOBAL IMMUNOTHERAPY BY COMPANY
3.1 Global Immunotherapy Breakdown Data by Company
3.1.1 Global Immunotherapy Annual Sales by Company (2020-2022)
3.1.2 Global Immunotherapy Sales Market Share by Company (2020-2022)
3.2 Global Immunotherapy Annual Revenue by Company (2020-2022)
3.2.1 Global Immunotherapy Revenue by Company (2020-2022)
3.2.2 Global Immunotherapy Revenue Market Share by Company (2020-2022)
3.3 Global Immunotherapy Sale Price by Company
3.4 Key Manufacturers Immunotherapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immunotherapy Product Location Distribution
3.4.2 Players Immunotherapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMMUNOTHERAPY BY GEOGRAPHIC REGION
4.1 World Historic Immunotherapy Market Size by Geographic Region (2017-2022)
4.1.1 Global Immunotherapy Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Immunotherapy Annual Revenue by Geographic Region
4.2 World Historic Immunotherapy Market Size by Country/Region (2017-2022)
4.2.1 Global Immunotherapy Annual Sales by Country/Region (2017-2022)
4.2.2 Global Immunotherapy Annual Revenue by Country/Region
4.3 Americas Immunotherapy Sales Growth
4.4 APAC Immunotherapy Sales Growth
4.5 Europe Immunotherapy Sales Growth
4.6 Middle East & Africa Immunotherapy Sales Growth
5 AMERICAS
5.1 Americas Immunotherapy Sales by Country
5.1.1 Americas Immunotherapy Sales by Country (2017-2022)
5.1.2 Americas Immunotherapy Revenue by Country (2017-2022)
5.2 Americas Immunotherapy Sales by Type
5.3 Americas Immunotherapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunotherapy Sales by Region
6.1.1 APAC Immunotherapy Sales by Region (2017-2022)
6.1.2 APAC Immunotherapy Revenue by Region (2017-2022)
6.2 APAC Immunotherapy Sales by Type
6.3 APAC Immunotherapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immunotherapy by Country
7.1.1 Europe Immunotherapy Sales by Country (2017-2022)
7.1.2 Europe Immunotherapy Revenue by Country (2017-2022)
7.2 Europe Immunotherapy Sales by Type
7.3 Europe Immunotherapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunotherapy by Country
8.1.1 Middle East & Africa Immunotherapy Sales by Country (2017-2022)
8.1.2 Middle East & Africa Immunotherapy Revenue by Country (2017-2022)
8.2 Middle East & Africa Immunotherapy Sales by Type
8.3 Middle East & Africa Immunotherapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immunotherapy
10.3 Manufacturing Process Analysis of Immunotherapy
10.4 Industry Chain Structure of Immunotherapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immunotherapy Distributors
11.3 Immunotherapy Customer
12 WORLD FORECAST REVIEW FOR IMMUNOTHERAPY BY GEOGRAPHIC REGION
12.1 Global Immunotherapy Market Size Forecast by Region
12.1.1 Global Immunotherapy Forecast by Region (2023-2028)
12.1.2 Global Immunotherapy Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immunotherapy Forecast by Type
12.7 Global Immunotherapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbvie
13.1.1 Abbvie Company Information
13.1.2 Abbvie Immunotherapy Product Offered
13.1.3 Abbvie Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbvie Main Business Overview
13.1.5 Abbvie Latest Developments
13.2 Amgen, Inc.
13.2.1 Amgen, Inc. Company Information
13.2.2 Amgen, Inc. Immunotherapy Product Offered
13.2.3 Amgen, Inc. Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Amgen, Inc. Main Business Overview
13.2.5 Amgen, Inc. Latest Developments
13.3 Biogen
13.3.1 Biogen Company Information
13.3.2 Biogen Immunotherapy Product Offered
13.3.3 Biogen Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biogen Main Business Overview
13.3.5 Biogen Latest Developments
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Information
13.4.2 Bristol-Myers Squibb Immunotherapy Product Offered
13.4.3 Bristol-Myers Squibb Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bristol-Myers Squibb Main Business Overview
13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Celgene
13.5.1 Celgene Company Information
13.5.2 Celgene Immunotherapy Product Offered
13.5.3 Celgene Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Celgene Main Business Overview
13.5.5 Celgene Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Immunotherapy Product Offered
13.6.3 Johnson & Johnson Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Immunotherapy Product Offered
13.7.3 Merck Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Immunotherapy Product Offered
13.8.3 Novartis Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer Immunotherapy Product Offered
13.9.3 Pfizer Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 Roche
13.10.1 Roche Company Information
13.10.2 Roche Immunotherapy Product Offered
13.10.3 Roche Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Roche Main Business Overview
13.10.5 Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immunotherapy Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Immunotherapy Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Therapeutic Vaccines
Table 5. Major Players of Checkpoint Inhibitors
Table 6. Major Players of Non-Specific Immunotherapy
Table 7. Global Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 8. Global Immunotherapy Sales Market Share by Type (2017-2022)
Table 9. Global Immunotherapy Revenue by Type (2017-2022) & ($ million)
Table 10. Global Immunotherapy Revenue Market Share by Type (2017-2022)
Table 11. Global Immunotherapy Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 13. Global Immunotherapy Sales Market Share by Application (2017-2022)
Table 14. Global Immunotherapy Revenue by Application (2017-2022)
Table 15. Global Immunotherapy Revenue Market Share by Application (2017-2022)
Table 16. Global Immunotherapy Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Immunotherapy Sales by Company (2020-2022) & (K Units)
Table 18. Global Immunotherapy Sales Market Share by Company (2020-2022)
Table 19. Global Immunotherapy Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Immunotherapy Revenue Market Share by Company (2020-2022)
Table 21. Global Immunotherapy Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Immunotherapy Producing Area Distribution and Sales Area
Table 23. Players Immunotherapy Products Offered
Table 24. Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Immunotherapy Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Immunotherapy Sales Market Share Geographic Region (2017-2022)
Table 29. Global Immunotherapy Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Immunotherapy Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Immunotherapy Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Immunotherapy Sales Market Share by Country/Region (2017-2022)
Table 33. Global Immunotherapy Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Immunotherapy Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 36. Americas Immunotherapy Sales Market Share by Country (2017-2022)
Table 37. Americas Immunotherapy Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Immunotherapy Revenue Market Share by Country (2017-2022)
Table 39. Americas Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 40. Americas Immunotherapy Sales Market Share by Type (2017-2022)
Table 41. Americas Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 42. Americas Immunotherapy Sales Market Share by Application (2017-2022)
Table 43. APAC Immunotherapy Sales by Region (2017-2022) & (K Units)
Table 44. APAC Immunotherapy Sales Market Share by Region (2017-2022)
Table 45. APAC Immunotherapy Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Immunotherapy Revenue Market Share by Region (2017-2022)
Table 47. APAC Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 48. APAC Immunotherapy Sales Market Share by Type (2017-2022)
Table 49. APAC Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 50. APAC Immunotherapy Sales Market Share by Application (2017-2022)
Table 51. Europe Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 52. Europe Immunotherapy Sales Market Share by Country (2017-2022)
Table 53. Europe Immunotherapy Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Immunotherapy Revenue Market Share by Country (2017-2022)
Table 55. Europe Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 56. Europe Immunotherapy Sales Market Share by Type (2017-2022)
Table 57. Europe Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 58. Europe Immunotherapy Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Immunotherapy Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Immunotherapy Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Immunotherapy Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Immunotherapy Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Immunotherapy Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Immunotherapy
Table 68. Key Market Challenges & Risks of Immunotherapy
Table 69. Key Industry Trends of Immunotherapy
Table 70. Immunotherapy Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Immunotherapy Distributors List
Table 73. Immunotherapy Customer List
Table 74. Global Immunotherapy Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Immunotherapy Sales Market Forecast by Region
Table 76. Global Immunotherapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Immunotherapy Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Immunotherapy Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Immunotherapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Immunotherapy Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Immunotherapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Immunotherapy Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Immunotherapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Immunotherapy Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Immunotherapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Immunotherapy Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Immunotherapy Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Immunotherapy Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Immunotherapy Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Immunotherapy Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Immunotherapy Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Immunotherapy Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Immunotherapy Revenue Market Share Forecast by Application (2023-2028)
Table 94. Abbvie Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 95. Abbvie Immunotherapy Product Offered
Table 96. Abbvie Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Abbvie Main Business
Table 98. Abbvie Latest Developments
Table 99. Amgen, Inc. Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 100. Amgen, Inc. Immunotherapy Product Offered
Table 101. Amgen, Inc. Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Amgen, Inc. Main Business
Table 103. Amgen, Inc. Latest Developments
Table 104. Biogen Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 105. Biogen Immunotherapy Product Offered
Table 106. Biogen Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Biogen Main Business
Table 108. Biogen Latest Developments
Table 109. Bristol-Myers Squibb Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 110. Bristol-Myers Squibb Immunotherapy Product Offered
Table 111. Bristol-Myers Squibb Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Bristol-Myers Squibb Main Business
Table 113. Bristol-Myers Squibb Latest Developments
Table 114. Celgene Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 115. Celgene Immunotherapy Product Offered
Table 116. Celgene Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Celgene Main Business
Table 118. Celgene Latest Developments
Table 119. Johnson & Johnson Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 120. Johnson & Johnson Immunotherapy Product Offered
Table 121. Johnson & Johnson Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Johnson & Johnson Main Business
Table 123. Johnson & Johnson Latest Developments
Table 124. Merck Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 125. Merck Immunotherapy Product Offered
Table 126. Merck Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Merck Main Business
Table 128. Merck Latest Developments
Table 129. Novartis Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 130. Novartis Immunotherapy Product Offered
Table 131. Novartis Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Novartis Main Business
Table 133. Novartis Latest Developments
Table 134. Pfizer Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 135. Pfizer Immunotherapy Product Offered
Table 136. Pfizer Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Pfizer Main Business
Table 138. Pfizer Latest Developments
Table 139. Roche Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 140. Roche Immunotherapy Product Offered
Table 141. Roche Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Roche Main Business
Table 143. Roche Latest Developments
Table 1. Immunotherapy Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Immunotherapy Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Therapeutic Vaccines
Table 5. Major Players of Checkpoint Inhibitors
Table 6. Major Players of Non-Specific Immunotherapy
Table 7. Global Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 8. Global Immunotherapy Sales Market Share by Type (2017-2022)
Table 9. Global Immunotherapy Revenue by Type (2017-2022) & ($ million)
Table 10. Global Immunotherapy Revenue Market Share by Type (2017-2022)
Table 11. Global Immunotherapy Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 13. Global Immunotherapy Sales Market Share by Application (2017-2022)
Table 14. Global Immunotherapy Revenue by Application (2017-2022)
Table 15. Global Immunotherapy Revenue Market Share by Application (2017-2022)
Table 16. Global Immunotherapy Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Immunotherapy Sales by Company (2020-2022) & (K Units)
Table 18. Global Immunotherapy Sales Market Share by Company (2020-2022)
Table 19. Global Immunotherapy Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Immunotherapy Revenue Market Share by Company (2020-2022)
Table 21. Global Immunotherapy Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Immunotherapy Producing Area Distribution and Sales Area
Table 23. Players Immunotherapy Products Offered
Table 24. Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Immunotherapy Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Immunotherapy Sales Market Share Geographic Region (2017-2022)
Table 29. Global Immunotherapy Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Immunotherapy Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Immunotherapy Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Immunotherapy Sales Market Share by Country/Region (2017-2022)
Table 33. Global Immunotherapy Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Immunotherapy Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 36. Americas Immunotherapy Sales Market Share by Country (2017-2022)
Table 37. Americas Immunotherapy Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Immunotherapy Revenue Market Share by Country (2017-2022)
Table 39. Americas Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 40. Americas Immunotherapy Sales Market Share by Type (2017-2022)
Table 41. Americas Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 42. Americas Immunotherapy Sales Market Share by Application (2017-2022)
Table 43. APAC Immunotherapy Sales by Region (2017-2022) & (K Units)
Table 44. APAC Immunotherapy Sales Market Share by Region (2017-2022)
Table 45. APAC Immunotherapy Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Immunotherapy Revenue Market Share by Region (2017-2022)
Table 47. APAC Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 48. APAC Immunotherapy Sales Market Share by Type (2017-2022)
Table 49. APAC Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 50. APAC Immunotherapy Sales Market Share by Application (2017-2022)
Table 51. Europe Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 52. Europe Immunotherapy Sales Market Share by Country (2017-2022)
Table 53. Europe Immunotherapy Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Immunotherapy Revenue Market Share by Country (2017-2022)
Table 55. Europe Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 56. Europe Immunotherapy Sales Market Share by Type (2017-2022)
Table 57. Europe Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 58. Europe Immunotherapy Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Immunotherapy Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Immunotherapy Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Immunotherapy Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Immunotherapy Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Immunotherapy Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Immunotherapy
Table 68. Key Market Challenges & Risks of Immunotherapy
Table 69. Key Industry Trends of Immunotherapy
Table 70. Immunotherapy Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Immunotherapy Distributors List
Table 73. Immunotherapy Customer List
Table 74. Global Immunotherapy Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Immunotherapy Sales Market Forecast by Region
Table 76. Global Immunotherapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Immunotherapy Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Immunotherapy Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Immunotherapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Immunotherapy Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Immunotherapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Immunotherapy Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Immunotherapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Immunotherapy Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Immunotherapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Immunotherapy Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Immunotherapy Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Immunotherapy Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Immunotherapy Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Immunotherapy Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Immunotherapy Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Immunotherapy Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Immunotherapy Revenue Market Share Forecast by Application (2023-2028)
Table 94. Abbvie Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 95. Abbvie Immunotherapy Product Offered
Table 96. Abbvie Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Abbvie Main Business
Table 98. Abbvie Latest Developments
Table 99. Amgen, Inc. Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 100. Amgen, Inc. Immunotherapy Product Offered
Table 101. Amgen, Inc. Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Amgen, Inc. Main Business
Table 103. Amgen, Inc. Latest Developments
Table 104. Biogen Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 105. Biogen Immunotherapy Product Offered
Table 106. Biogen Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Biogen Main Business
Table 108. Biogen Latest Developments
Table 109. Bristol-Myers Squibb Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 110. Bristol-Myers Squibb Immunotherapy Product Offered
Table 111. Bristol-Myers Squibb Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Bristol-Myers Squibb Main Business
Table 113. Bristol-Myers Squibb Latest Developments
Table 114. Celgene Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 115. Celgene Immunotherapy Product Offered
Table 116. Celgene Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Celgene Main Business
Table 118. Celgene Latest Developments
Table 119. Johnson & Johnson Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 120. Johnson & Johnson Immunotherapy Product Offered
Table 121. Johnson & Johnson Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Johnson & Johnson Main Business
Table 123. Johnson & Johnson Latest Developments
Table 124. Merck Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 125. Merck Immunotherapy Product Offered
Table 126. Merck Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Merck Main Business
Table 128. Merck Latest Developments
Table 129. Novartis Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 130. Novartis Immunotherapy Product Offered
Table 131. Novartis Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Novartis Main Business
Table 133. Novartis Latest Developments
Table 134. Pfizer Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 135. Pfizer Immunotherapy Product Offered
Table 136. Pfizer Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Pfizer Main Business
Table 138. Pfizer Latest Developments
Table 139. Roche Basic Information, Immunotherapy Manufacturing Base, Sales Area and Its Competitors
Table 140. Roche Immunotherapy Product Offered
Table 141. Roche Immunotherapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Roche Main Business
Table 143. Roche Latest Developments
LIST OF FIGURES
Figure 1. Picture of Immunotherapy
Figure 2. Immunotherapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immunotherapy Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Immunotherapy Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Immunotherapy Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Product Picture of Therapeutic Vaccines
Figure 11. Product Picture of Checkpoint Inhibitors
Figure 12. Product Picture of Non-Specific Immunotherapy
Figure 13. Global Immunotherapy Sales Market Share by Type in 2021
Figure 14. Global Immunotherapy Revenue Market Share by Type (2017-2022)
Figure 15. Immunotherapy Consumed in Oncology
Figure 16. Global Immunotherapy Market: Oncology (2017-2022) & (K Units)
Figure 17. Immunotherapy Consumed in Inflammation
Figure 18. Global Immunotherapy Market: Inflammation (2017-2022) & (K Units)
Figure 19. Immunotherapy Consumed in Central Nervous System
Figure 20. Global Immunotherapy Market: Central Nervous System (2017-2022) & (K Units)
Figure 21. Immunotherapy Consumed in Others
Figure 22. Global Immunotherapy Market: Others (2017-2022) & (K Units)
Figure 23. Global Immunotherapy Sales Market Share by Application (2017-2022)
Figure 24. Global Immunotherapy Revenue Market Share by Application in 2021
Figure 25. Immunotherapy Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Immunotherapy Revenue Market Share by Company in 2021
Figure 27. Global Immunotherapy Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Immunotherapy Revenue Market Share by Geographic Region in 2021
Figure 29. Global Immunotherapy Sales Market Share by Region (2017-2022)
Figure 30. Global Immunotherapy Revenue Market Share by Country/Region in 2021
Figure 31. Americas Immunotherapy Sales 2017-2022 (K Units)
Figure 32. Americas Immunotherapy Revenue 2017-2022 ($ Millions)
Figure 33. APAC Immunotherapy Sales 2017-2022 (K Units)
Figure 34. APAC Immunotherapy Revenue 2017-2022 ($ Millions)
Figure 35. Europe Immunotherapy Sales 2017-2022 (K Units)
Figure 36. Europe Immunotherapy Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Immunotherapy Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Immunotherapy Revenue 2017-2022 ($ Millions)
Figure 39. Americas Immunotherapy Sales Market Share by Country in 2021
Figure 40. Americas Immunotherapy Revenue Market Share by Country in 2021
Figure 41. United States Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Immunotherapy Sales Market Share by Region in 2021
Figure 46. APAC Immunotherapy Revenue Market Share by Regions in 2021
Figure 47. China Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Immunotherapy Sales Market Share by Country in 2021
Figure 54. Europe Immunotherapy Revenue Market Share by Country in 2021
Figure 55. Germany Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Immunotherapy Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Immunotherapy Revenue Market Share by Country in 2021
Figure 62. Egypt Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Immunotherapy in 2021
Figure 68. Manufacturing Process Analysis of Immunotherapy
Figure 69. Industry Chain Structure of Immunotherapy
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 1. Picture of Immunotherapy
Figure 2. Immunotherapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immunotherapy Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Immunotherapy Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Immunotherapy Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Product Picture of Therapeutic Vaccines
Figure 11. Product Picture of Checkpoint Inhibitors
Figure 12. Product Picture of Non-Specific Immunotherapy
Figure 13. Global Immunotherapy Sales Market Share by Type in 2021
Figure 14. Global Immunotherapy Revenue Market Share by Type (2017-2022)
Figure 15. Immunotherapy Consumed in Oncology
Figure 16. Global Immunotherapy Market: Oncology (2017-2022) & (K Units)
Figure 17. Immunotherapy Consumed in Inflammation
Figure 18. Global Immunotherapy Market: Inflammation (2017-2022) & (K Units)
Figure 19. Immunotherapy Consumed in Central Nervous System
Figure 20. Global Immunotherapy Market: Central Nervous System (2017-2022) & (K Units)
Figure 21. Immunotherapy Consumed in Others
Figure 22. Global Immunotherapy Market: Others (2017-2022) & (K Units)
Figure 23. Global Immunotherapy Sales Market Share by Application (2017-2022)
Figure 24. Global Immunotherapy Revenue Market Share by Application in 2021
Figure 25. Immunotherapy Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Immunotherapy Revenue Market Share by Company in 2021
Figure 27. Global Immunotherapy Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Immunotherapy Revenue Market Share by Geographic Region in 2021
Figure 29. Global Immunotherapy Sales Market Share by Region (2017-2022)
Figure 30. Global Immunotherapy Revenue Market Share by Country/Region in 2021
Figure 31. Americas Immunotherapy Sales 2017-2022 (K Units)
Figure 32. Americas Immunotherapy Revenue 2017-2022 ($ Millions)
Figure 33. APAC Immunotherapy Sales 2017-2022 (K Units)
Figure 34. APAC Immunotherapy Revenue 2017-2022 ($ Millions)
Figure 35. Europe Immunotherapy Sales 2017-2022 (K Units)
Figure 36. Europe Immunotherapy Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Immunotherapy Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Immunotherapy Revenue 2017-2022 ($ Millions)
Figure 39. Americas Immunotherapy Sales Market Share by Country in 2021
Figure 40. Americas Immunotherapy Revenue Market Share by Country in 2021
Figure 41. United States Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Immunotherapy Sales Market Share by Region in 2021
Figure 46. APAC Immunotherapy Revenue Market Share by Regions in 2021
Figure 47. China Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Immunotherapy Sales Market Share by Country in 2021
Figure 54. Europe Immunotherapy Revenue Market Share by Country in 2021
Figure 55. Germany Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Immunotherapy Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Immunotherapy Revenue Market Share by Country in 2021
Figure 62. Egypt Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Immunotherapy Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Immunotherapy in 2021
Figure 68. Manufacturing Process Analysis of Immunotherapy
Figure 69. Industry Chain Structure of Immunotherapy
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
